P16/MTS1 and pRB expression in endometrial carcinomas

Virchows Archiv

Volumn 434, Issue 1, 1999, Pages 23-28

  Milde Langosch, Karin ^a   Riethdorf, Lutz ^a   Bamberger, Ana Maria ^a   Löning, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Carcinoma; Endometrium; MTS1; p16; Rb; Uterus

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESODERM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL METAPLASIA; UTERUS CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN;

EID: 0032941480     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050300     Document Type: Article

References (27)

1. 1. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93:13742-13747
2. 2. Bamberger A-M, Bamberger CM, Wald M, Kratzmeier M, Schulte HM (1996) Protein kinase C (PKC) isoenzyme expression pattern as an indicator of proliferative activity in uterine tumor cells. Mol Cell Endocrinol 123:81-88
3. 3. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J (1996) The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56:5475-5483
4. 4. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-416
5. 5. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Sexmour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Gen 8:27-32
6. 6. Elledge SJ, Winston J, Harper JW (1996) A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388-393
7. INK4A in archival human solid tumors: correlation with retinoblastoma expression. Cancer Res 55:6006-6011
8. 8. Hatta Y, Hirama T, Takeuchi S, Lee E, Pham E, Miller CW, Strohmeyer T, Wilczynski SP, Melmed S, Koeffler HP (1995) Alterations of the p16 (MST1) gene in testicular, ovarian, and endometrial malignancies. J Urol 154:1954-1957
9. 9. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530
10. 10. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally S, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15-21
11. 11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Szockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
12. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res 56:5557-5562
13. 13. Li S-F, Shiozawa T, Nakayama K, Nikaido T, Fujii S (1996) Stepwise abnormality of sex steroid hormone receptors, tumor supporessor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer 77:321-329
14. 14. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506
15. 15. Milde-Langosch K, Ocon E, Becker G, Löning T (1998) P16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression, associated with hypermethylation or mutation in endometrioid and mucinous tumors. Int J Cancer [Pred Oncol] 79:61-65
16. 16. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y ( 1994) Frequent somatic mutation of the MTS1/CDK4I (Multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinomas. Cancer Res 54:3396-3397
17. 17. Niemann TH, Yilmaz AG, McGaughy VR, Vaccarello L (1997) Retinoblastoma protein expression in endometrial hyperplasia and carcinoma. Gynecol Oncol 65:232-236
18. 18. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG (1997) Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 14:811-818
19. 19. Riethdorf L, Begemann C, Riethdorf S, Milde-Langosch K, Löning T (1996) Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis. Virchows Arch 428:47-51
20. 20. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37
21. INK4A as a human tumor suppressor. Biochim Biophys Acta 1242:165-169
22. INK4 in human endometrioid-type endometrial carcinoma. Cancer 80:2250-2256
23. 23. Spruck CH, Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin M-F, Gonzales F, Tsai IC, Jones PA (1994) P16 gene in uncultures tumours. Nature 370:183-184
24. 24. Sun Y, Hegamyer G, Colburn NH (1993) Nasopharyngeal carcinoma shows no detectable retinoblastoma gene alterations. Oncogene 8:791-795
25. INK4B alterations in primary gynecologic malignancy. Gynecol Oncol 65:319-324
26. 26. Yaginuma Y, Katayama H, Kawai K, Duenas JC, Ishikawa M (1996) Analysis of the retinoblastoma gene in human endometrial carcinoma. Obstet Gynecol 87:755-759
27. 27. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA (1995) A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am J Pathol 146:620-625